SEC Filing Details
Document Details
Form
Filing Date
February 17, 2022
Document Date
February 15, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
MOTT DAVID M